HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.

Abstract
Glucagon-like peptide-2 (GLP-2) action is dependent on intestinal expression of IGF-I, and IGF-I action is modulated by IGF binding proteins (IGFBP). Our objective was to evaluate whether the intestinal response to GLP-2 or IGF-I is dependent on expression of IGFBP-3 and -5. Male, adult mice in six treatment groups, three wild-type (WT) and three double IGFBP-3/-5 knockout (KO), received twice daily intraperitoneal injections of GLP-2 (0.5 μg/g body wt), IGF-I (4 μg/g body wt), or PBS (vehicle) for 7 days. IGFBP-3/-5 KO mice showed a phenotype of lower plasma IGF-I concentration, but greater body weight and relative mass of visceral organs, compared with WT mice (P < 0.001). WT mice showed jejunal growth with either IGF-I or GLP-2 treatment. In KO mice, IGF-I did not stimulate jejunal growth, crypt mitosis, sucrase activity, and IGF-I receptor (IGF-IR) expression, suggesting that the intestinotrophic actions of IGF-I are dependent on expression of IGFBP-3 and -5. In KO mice, GLP-2 induced significant increases in jejunal mucosal cellularity, crypt mitosis, villus height, and crypt depth that was associated with increased expression of the ErbB ligand epiregulin and decreased expression of IGF-I and IGF-IR. This suggests that in KO mice, GLP-2 action in jejunal mucosa is independent of the IGF-I system and linked with ErbB ligands. In summary, the intestinotrophic actions of IGF-I, but not GLP-2, in mucosa are dependent on IGFBP-3 and -5. These findings support the role of multiple downstream mediators for the mucosal growth induced by GLP-2.
AuthorsSangita G Murali, Adam S Brinkman, Patrick Solverson, Wing Pun, John E Pintar, Denise M Ney
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 302 Issue 8 Pg. G794-804 (Apr 15 2012) ISSN: 1522-1547 [Electronic] United States
PMID22281475 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Glucagon-Like Peptide 2
  • Insulin-Like Growth Factor Binding Protein 3
  • Insulin-Like Growth Factor Binding Protein 5
  • RNA
  • Insulin-Like Growth Factor I
Topics
  • Analysis of Variance
  • Animals
  • Body Weight (genetics, physiology)
  • Colon (anatomy & histology, drug effects, growth & development)
  • Genes, erbB (physiology)
  • Glucagon-Like Peptide 2 (pharmacology)
  • Insulin-Like Growth Factor Binding Protein 3 (genetics, physiology)
  • Insulin-Like Growth Factor Binding Protein 5 (genetics, physiology)
  • Insulin-Like Growth Factor I (pharmacology)
  • Intestinal Mucosa (drug effects, growth & development)
  • Intestine, Small (anatomy & histology, drug effects, growth & development)
  • Intestines (anatomy & histology, drug effects, growth & development)
  • Kidney (growth & development)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Organ Size (genetics, physiology)
  • RNA (biosynthesis, isolation & purification)
  • Real-Time Polymerase Chain Reaction
  • Spleen (growth & development)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: